Echistatin a1 (reduced), cyclic (2®11),(7®32),(8®37),(20®39)-tetrakis(disulfide)(9CI) (154303-05-6)
Identification |
Properties |
Safety Data |
|
 |
Other Product
- Plasminogen activator(human tissue-type 2-chain form), 84-L-serine-, cyclic (6®36),(34®43),(51®73),(56®62),(75®83),(92®173),(113®155),(144®168),(180®261),(201®243),(232®256)-undecakis(disulfide), cyclic(32'®48'),(40'®109'),(134'®209),(166'®182'),(199'®227')-pentakis(disulfide), cyclic(264®120')-disulfide
- Guanylin (humanreduced), cyclic (4®12),(7®15)-bis(disulfide) (9CI)
- 11-21-Endothelin 1(swine reduced), cyclic (11®15)-disulfide
- Neuropeptide F 1(Locusta migratoria reduced), bimol. cyclic (1®6'),(6®1')-bis(disulfide) (9CI)
- Endothelin 1 (swinereduced), 1-(L-2-aminobutanoic acid)-15-(L-2-aminobutanoic acid)-, cyclic (3®11)-disulfide (9CI)
- Angiotensin II,1-cysteine-5-L-isoleucine-8-L-cysteine-, cyclic (1®8)-disulfide (9CI)
- L-Valine,N-(2-quinoxalinylcarbonyl)-L-seryl-L-alanyl-L-cysteinyl-, bimol. (4®1'),(4'®1)-dilactone, cyclic (3®3')-disulfide (9CI)
- L-Valine,N-(2-quinoxalinylcarbonyl)-D-seryl-L-alanyl-N-methyl-L-cysteinyl-, (4®1'),(4'®1)-dilactone, cyclic (3®3')-disulfide (9CI)
- Kallidin, cyclic (10®2)-peptide (9CI)
- Interleukin 6 (humanclone HGF15 protein moiety reduced), 1-(1-L-alanyl-L-proline)-, cyclic (44®50),(73®83)-bis(disulfide) (9CI)
- 1-223-Colony-stimulatingfactor 1 (human clone p3ACSF-69 protein moiety), cyclic (7®90),(48®139),(102®146)-tris(disulfide), bimol.cyclic (31®31'),(157®157'),(159®159')-tris(disulfide)
- Insulin (cattle-Breduced), 30-de-L-alanine-, cyclic (7®19)-disulfide (9CI)
- L-Cysteinamide,D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-,cyclic (2®7)-disulfide (9CI)
- L-Threonine, L-a-aspartyl-L-threonyl-L-histidyl-L-phenylalanyl-L-prolyl-L-isoleucyl-L-cysteinyl-L-isoleucyl-L-phenylalanyl-L-cysteinyl-L-cysteinylglycyl-L-cysteinyl-L-cysteinyl-L-histidyl-L-arginyl-L-seryl-L-lysyl-L-cysteinylglycyl-L-methionyl-L-cysteinyl-L-cysteinyl-L-lysyl-,cyclic (7®13),(10®23),(11®22),(14®19)-tetrakis(disulfide)
- D-Valinamide,L-tyrosyl-D-cysteinyl-L-phenylalanyl-3-mercapto-, cyclic (2®4)-disulfide (9CI)
- Echistatin a1 (reduced) (9CI)
- b-D-Glucopyranose, cyclic 3®2':6®2-[(1R)-4-(6-carboxy-2,3,4-trihydroxyphenoxy)-4',5,5',6,6'-pentahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate]cyclic 2®7:4®5-[(2R,6R)-3,6-dihydro-2,9,10,11,11-pentahydroxy-3-oxo-2,6-methano-2H-1-benzoxocin-5,7-dicarboxylate]1-(3,4,5-trihydroxybenzoate), 4-ester with b-D-glucopyranose1,2,3,6-tetrakis(3,4,5-trihydroxybenzoate) (9CI)
- L-Valine,N-9-acridinyl-D-seryl-L-alanyl-L-cysteinyl-, bimol. (4®1'),(4'®1)-dilactone, cyclic (3®3')-disulfide (9CI)
- Endothelin 1 (swinereduced), 3-L-alanine-11-L-alanine-, cyclic (1®15)-disulfide
- Endothelin 1 (swinereduced), 1-L-alanine-15-L-alanine-, cyclic (3®11)-disulfide